Health Condition 1: C501- Malignant neoplasm of central portion of breast Health Condition 2: C501- Malignant neoplasm of central portion of breast
Conditions
Interventions
Intervention1: NIL: NIL
Intervention2: Nil: Nil
Sponsors
NGSM Institute of Pharmaceutical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female breast cancer patients, aged above 18 years, who had undergone adjuvant chemotherapy. 2. Patients with normal haemoglobin count (Greater than or equal to 12 g/dl) before initiation of first cycle of adjuvant chemotherapy
Exclusion criteria
Exclusion criteria: 1. Patients who received blood transfusion within two weeks before chemotherapy 2. Patients with metastatic breast cancer 3. Patients who had underwent experimental trial of chemotherapy 4. Patients with incomplete medical records
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| By identifying the factors associated with anemia among breast cancer patients undergoing chemotherapy, this study is expected to offer valuable insights for refining supportive care strategiesTimepoint: 8 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To help clinicians in early risk assessment and to plan interventions to improve patient outcomes.Timepoint: 8 months | — |
Countries
India
Contacts
Public ContactNandakumar UP
NGSM Institute of Pharmaceutical Sciences
Outcome results
None listed